Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...
Carbon Credit Charts.
Carbon Streaming Corp. (OFSTF)
Base Carbon Inc. (BCBNF)
Live Carbon Prices Today
The Carbon Strategy ETF (NYSE: KARB) is an actively managed exchange-traded fund that uses as...
Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.
The Higher it Goes, The More Nervous we Get.
LIVE QUOTE
Not much to report here, other then there could be news any day, any week....
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super Foods, Expected...
FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been a gut wrenching couple years for shareholders. Is it big...
Scalpers Get Scalped!
Go Big or go Home. SEC Charges Eight Social Media Influencers in $100 Million Profit Stock Scheme.
SEC Charges Eight Social Media Influencers in $100...
Adding Unicycive (UNCY) $0.75 to the Watch List.
Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is a biotech...
Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process.
Lightly traded (400,000...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude.
We...
Alzheimer Drug Trials
A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022
Eli Lilly CEO David Ricks was confident last...















